PL2923208T3 - Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi - Google Patents

Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi

Info

Publication number
PL2923208T3
PL2923208T3 PL13792933T PL13792933T PL2923208T3 PL 2923208 T3 PL2923208 T3 PL 2923208T3 PL 13792933 T PL13792933 T PL 13792933T PL 13792933 T PL13792933 T PL 13792933T PL 2923208 T3 PL2923208 T3 PL 2923208T3
Authority
PL
Poland
Prior art keywords
risk
determining
methods
host disease
versus host
Prior art date
Application number
PL13792933T
Other languages
English (en)
Inventor
Olivier Hermine
Marie Thérèse RUBIO
Marie BOUILLIE
Maria LEITE DE MORAES
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Centre National De La Recherche Scientifique (Cnrs)
Assistance Publique Hôpitaux De Paris
Université Paris Descartes
Imagine Institut Des Maladies Génétiques Necker Enfants Malades
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm), Centre National De La Recherche Scientifique (Cnrs), Assistance Publique Hôpitaux De Paris, Université Paris Descartes, Imagine Institut Des Maladies Génétiques Necker Enfants Malades filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of PL2923208T3 publication Critical patent/PL2923208T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/55—IL-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/7051—T-cell receptor (TcR)-CD3 complex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL13792933T 2012-11-21 2013-11-21 Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi PL2923208T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306445 2012-11-21
EP13792933.7A EP2923208B1 (en) 2012-11-21 2013-11-21 Methods for determining the risk of acute graft versus host disease
PCT/EP2013/074407 WO2014079946A1 (en) 2012-11-21 2013-11-21 Methods for determining the risk of acute graft versus host disease

Publications (1)

Publication Number Publication Date
PL2923208T3 true PL2923208T3 (pl) 2019-09-30

Family

ID=47297066

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13792933T PL2923208T3 (pl) 2012-11-21 2013-11-21 Sposoby określania ryzyka ostrej choroby przeszczep przeciwko gospodarzowi

Country Status (10)

Country Link
US (1) US10151745B2 (pl)
EP (1) EP2923208B1 (pl)
JP (1) JP6599233B2 (pl)
CN (1) CN105122067B (pl)
AU (1) AU2013349706B2 (pl)
CA (1) CA2892482C (pl)
DK (1) DK2923208T3 (pl)
ES (1) ES2719255T3 (pl)
PL (1) PL2923208T3 (pl)
WO (1) WO2014079946A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101520534B1 (ko) 2012-05-07 2015-05-21 고려대학교 산학협력단 말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법
EP3617229B1 (en) * 2017-04-28 2024-03-13 Yamada, Ken-Ichi Detection reagent and kit for identifying acidic state and glycation state of low density lipoprotein
JP6943386B2 (ja) 2017-04-28 2021-09-29 山田 健一 脂質由来のラジカル体の検出方法およびラジカル体由来の化合物
US11713487B2 (en) * 2017-07-14 2023-08-01 The Regents Of The University Of California Methods of predicting transplant rejection risk
CN107831225B (zh) * 2017-10-13 2021-08-10 苏州大学附属第一医院 硬脂酸/软脂酸组合作为aGVHD疾病诊断标志物的应用
CN115710576A (zh) 2018-02-01 2023-02-24 Nkmax有限公司 产生天然杀伤细胞的方法和用于治疗癌症的组合物
WO2019178143A1 (en) * 2018-03-12 2019-09-19 The Regents Of The University Of California Assessing transplant rejection status by analysis of t-cell receptor subunit repertoire diversity
CN111208223B (zh) * 2020-01-13 2023-01-17 浙江大学 心脏死亡后捐献受体术前预警移植肾延迟复功的代谢物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0559081A (ja) 1991-08-29 1993-03-09 Kirin Brewery Co Ltd 新規スフインゴ糖脂質、その製造法および使用
TW261533B (pl) 1992-07-16 1995-11-01 Kirin Brewery
ATE191916T1 (de) 1992-10-22 2000-05-15 Kirin Brewery Neues sphingolglycolipid und verwendung davon
US5780441A (en) 1993-04-15 1998-07-14 Kirin Beer Kabushiki Kaisha Sphingoglycolipid compounds and therapeutic uses thereof
EP1520583B1 (en) 1997-04-10 2009-01-28 Kyowa Hakko Kirin Co., Ltd. NKT cell-activating agents containing alpha-glycosylceramides
US20050069546A1 (en) * 2003-09-30 2005-03-31 Yaron Ilan Educated NKT cells and their uses in the treatment of immune-related disorders
US20120238460A1 (en) * 2007-11-08 2012-09-20 Dana-Farber Cancer Institute, Inc. Rantes levels as a diagnostic and therapeutic for acute graft versus host disease
CN101402941A (zh) * 2008-11-11 2009-04-08 章毅 从脐带血中扩增Vα24NKT细胞的方法
DE102010037622B4 (de) * 2010-09-17 2012-07-12 Lophius Biosciences Gmbh Verfahren zum Nachweis, Differenzieren und Quantifizieren von T-Zellpopulationen mittels der Reverse Transkription quantitativen Real-Time PCR (RT-qPCR) Technologie

Also Published As

Publication number Publication date
CN105122067B (zh) 2017-07-11
ES2719255T3 (es) 2019-07-09
AU2013349706B2 (en) 2019-08-22
EP2923208A1 (en) 2015-09-30
JP2016503302A (ja) 2016-02-04
US10151745B2 (en) 2018-12-11
AU2013349706A1 (en) 2015-06-11
US20150301022A1 (en) 2015-10-22
WO2014079946A1 (en) 2014-05-30
CA2892482A1 (en) 2014-05-30
DK2923208T3 (en) 2019-04-15
CN105122067A (zh) 2015-12-02
JP6599233B2 (ja) 2019-10-30
CA2892482C (en) 2022-11-08
EP2923208B1 (en) 2019-01-16

Similar Documents

Publication Publication Date Title
IL254311B (en) Centrifuge
IL243976B (en) kdm1a inhibitors for disease treatment
IL235512A0 (en) New methods
GB201505407D0 (en) Methods for discovering therapeutic targets
EP3041576A4 (en) Methods for detecting renal disease
AU350549S (en) Breathalyzer
ZA201408955B (en) Anti-blys antibody
EP2808681A4 (en) breathalyser
ZA201406925B (en) Biocontrol
EP2891924A4 (en) TONER
EP2870158A4 (en) PROTEIN KINASE INHIBITORS
AU345873S (en) Pan
GB2506114B (en) Boot
GB201214440D0 (en) Kidney disease biomarker
EP2855484A4 (en) PROTEIN KINASE INHIBITORS
IL236132B (en) Uoglobulin-based method for determining the biological activity of defibrotide
GB201317621D0 (en) Kidney disease biomarker
ES2687237T8 (es) Dispositivo de suspensión para muebles de pared
GB201201132D0 (en) Automatic determining of file transfer mode
GB201208910D0 (en) Emulsion
SG10201704145RA (en) Biotinylated protein
GB201213672D0 (en) Protein
GB201215268D0 (en) Boot heater
GB201212144D0 (en) Blood rey rooters
GB2525829B (en) Drum mallet